131 related articles for article (PubMed ID: 35532768)
1. Adalimumab-Induced Psoriasis with Severe Alopecia.
Kabbani M; El Sayed F
Skinmed; 2022; 20(2):136-138. PubMed ID: 35532768
[TBL] [Abstract][Full Text] [Related]
2. Adalimumab-induced scalp psoriasis with severe alopecia.
Özkur E; Altunay İK; Leblebici C; Topkarcı Z; Erdem Y
Dermatol Ther; 2019 Sep; 32(5):e13033. PubMed ID: 31350777
[TBL] [Abstract][Full Text] [Related]
3. Adalimumab-induced scalp psoriasis with severe alopecia as a paradoxical effect in a patient with Crohn's disease successfully treated with ustekinumab.
Koumaki D; Koumaki V; Katoulis A; Lagoudaki E; Boumpoucheropoulos S; Stefanidou M; Miaris O; Baltaga L; Evangelou G; Zografaki K; Krueger-Krasagakis SE; Krasagakis K
Dermatol Ther; 2020 Jul; 33(4):e13791. PubMed ID: 32510744
[No Abstract] [Full Text] [Related]
4. Adalimumab-related alopecia in a patient affected by psoriasis.
Melé-Ninot G; Expósito-Serrano V; Quintana Codina M; Iglesias Sancho M; Sánchez-Regaña M; Umbert Millet P; Salleras Redonnet M
Dermatol Online J; 2017 Jul; 23(7):. PubMed ID: 29469696
[TBL] [Abstract][Full Text] [Related]
5. Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease.
Toda-Brito H; Lopes L; Soares-Almeida L; Filipe P
Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632930
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical Induction of Psoriasis and Lichen Planus by Tumor Necrosis Factor-α Inhibitors.
Au S; Hernandez C
Skinmed; 2015; 13(5):403-5. PubMed ID: 26790515
[TBL] [Abstract][Full Text] [Related]
7. Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab.
Andrisani G; Marzo M; Celleno L; Guidi L; Papa A; Gasbarrini A; Armuzzi A
Eur Rev Med Pharmacol Sci; 2013 Oct; 17(20):2831-6. PubMed ID: 24174369
[TBL] [Abstract][Full Text] [Related]
8. Paradoxical pustular psoriasis induced by ustekinumab in a patient with Crohn's disease-associated spondyloarthropathy.
Benzaquen M; Flachaire B; Rouby F; Berbis P; Guis S
Rheumatol Int; 2018 Jul; 38(7):1297-1299. PubMed ID: 29705819
[TBL] [Abstract][Full Text] [Related]
9. Persistent neutrophilic scarring alopecia triggered by anti-TNF blockade for Crohn's disease.
Amschler K; Mc Broekaert S; Mohr J; Schön MP; Mößner R
Eur J Dermatol; 2018 Jun; 28(3):403-405. PubMed ID: 29976546
[No Abstract] [Full Text] [Related]
10. [Pityriasis amiantacea and folliculitis decalvans : An unusual manifestation associated with antitumor necrosis factor-α therapy].
Zamperetti M; Zelger B; Höpfl R
Hautarzt; 2017 Dec; 68(12):1007-1010. PubMed ID: 29038892
[TBL] [Abstract][Full Text] [Related]
11. Psoriatic Alopecia in a Patient With Crohn Disease: An Uncommon Manifestation of Tumor Necrosis Factor α Inhibitors.
Carrasquillo OY; Pabón-Cartagena G; Barrera-Llaurador J; Colón-Fontanez F; Martín-García RF
Cutis; 2021 Apr; 107(4):E48-E55. PubMed ID: 34096864
[TBL] [Abstract][Full Text] [Related]
12. Vedolizumab-associated psoriasis: until where does gut selectivity go?
Pereira Guedes T; Pedroto I; Lago P
Rev Esp Enferm Dig; 2020 Jul; 112(7):580-581. PubMed ID: 32496114
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients.
Wollina U; Hansel G; Koch A; Schönlebe J; Köstler E; Haroske G
Am J Clin Dermatol; 2008; 9(1):1-14. PubMed ID: 18092839
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-induced alopecia: alternative pathology and therapy.
Udkoff J; Cohen PR
Dermatol Online J; 2017 Jun; 23(6):. PubMed ID: 28633753
[TBL] [Abstract][Full Text] [Related]
15. [Scarring psoriatic alopecia].
Kretzschmar L; Bonsmann G; Metze D; Luger TA; Schwarz T
Hautarzt; 1995 Mar; 46(3):154-7. PubMed ID: 7759240
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial.
Hanauer S; Liedert B; Balser S; Brockstedt E; Moschetti V; Schreiber S
Lancet Gastroenterol Hepatol; 2021 Oct; 6(10):816-825. PubMed ID: 34388360
[TBL] [Abstract][Full Text] [Related]
17. Stricturing and Fistulizing Crohn's Disease Is Associated with Anti-tumor Necrosis Factor-Induced Psoriasis in Patients with Inflammatory Bowel Disease.
Weizman AV; Sharma R; Afzal NM; Xu W; Walsh S; Stempak JM; Nguyen GC; Croitoru K; Steinhart AH; Silverberg MS
Dig Dis Sci; 2018 Sep; 63(9):2430-2438. PubMed ID: 29736839
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of hidradenitis suppurativa in the setting of Crohn disease with combination adalimumab and ustekinumab.
Cline A; Pichardo RO
Dermatol Online J; 2019 Sep; 25(9):. PubMed ID: 31738849
[TBL] [Abstract][Full Text] [Related]
19. TNF inhibitor induced alopecia: an unusual form of psoriasiform alopecia that breaks the Renbök mold.
Craddock LN; Cooley DM; Endo JO; Longley BJ; Caldera F
Dermatol Online J; 2017 Mar; 23(3):. PubMed ID: 28329519
[TBL] [Abstract][Full Text] [Related]
20. Case of psoriasiform and pustular eruptions in addition to alopecia as a paradoxical reaction induced by infliximab.
Shimokata M; Namiki T; Tokoro S; Ugajin T; Miura K; Yokozeki H
J Dermatol; 2018 Dec; 45(12):e331-e333. PubMed ID: 29855072
[No Abstract] [Full Text] [Related]
[Next] [New Search]
